2026
Introduction
- What evidence supports the use of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) for management of anemia in chronic kidney disease (CKD)?
- How long should antibiotics be continued following an amputation for diabetic foot infection, particularly in cases of residual bone infection?
- Update: What are Major Pharmacotherapy Updates from the 2026 AHA/ASA Stroke Guidelines?
- What is the role of oral semaglutide (Wegovy) in weight loss for patients who are overweight or obese?
- What is the most recent information on managing MASLD/MASH in pediatric and adolescent patients?
- What information is available on the use and dosing of tranexamic acid (TXA) for major trauma?
- Is there evidence to support alternate-day dosing of oral iron for the treatment of iron deficiency anemia?
- What are current recommendations on the screening and management of hepatitis B infection in pregnancy?
- What Are the Latest Recommendations for Occupational HIV Post-Exposure Prophylaxis in Healthcare Settings?
- What data is available to support the use of neurokinin 3 (NK3) receptor antagonists for the management of vasomotor symptoms related to menopause?
- What literature is available to support the use of brensocatib in individuals with bronchiectasis?
- What is the role of insulin infusion in hypertriglyceridemia-induced acute pancreatitis?